Home Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma
Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma – Available in Pakistan
Rivaj HD Peaceable Lashes 02 worn showing comfortable natural eye look – View Product Detail
Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma – Available in Pakistan
Rivaj HD Peaceable Lashes 02 worn showing comfortable natural eye look – View Product Detail

Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma

Dorlol 5ml Eye Drops combine Dorzolamide HCl 20mg/mL and Timolol Maleate 5mg/mL in a dual-action ophthalmic formulation for reducing elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension. Delivers superior IOP control compared to either agent alone. Prescription-only eye drops available at Derma.pk.

Sale price Rs. 995

Pay in 3 Installments of

Rs.

381

Availability: In stock SKU: Derma.pk-234-202
Tags: Beta-Blocker Eye Drop Carbonic Anhydrase Inhibitor Dorlol Eye Drops Dorzolamide Timolol Eye Pressure Control Glaucoma Treatment IOP Reduction Ocular Hypertension Ophthalmic Solution prescription rx
Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma – Available in Pakistan

Dorlol 5ml Eye Drops 20mg/5mg – Dorzolamide & Timolol for Glaucoma

Rs. 995

Dorlol 5ml Eye Drops combine Dorzolamide Hydrochloride 20mg/mL, a carbonic anhydrase inhibitor, and Timolol Maleate 5mg/mL, a beta-adrenergic receptor blocker, in a dual-action ophthalmic formulation. Together they deliver superior intraocular pressure (IOP) reduction compared to either agent alone, making Dorlol a first-line option for patients with open-angle glaucoma or ocular hypertension.

Dorzolamide reduces the production of aqueous humour by inhibiting carbonic anhydrase II in the ciliary epithelium. Timolol decreases IOP through beta-blocking activity, reducing aqueous humour formation. The complementary mechanisms provide additive IOP-lowering efficacy, reducing the risk of progressive optic nerve damage and vision loss associated with untreated glaucoma.

Dorlol is indicated for patients in whom IOP is inadequately controlled on beta-blocker monotherapy or when combination therapy is considered appropriate. Remove contact lenses before instillation and wait at least 15 minutes before reinserting. Systemic beta-blockade effects (bradycardia, bronchospasm) may occur and must be considered in patients with asthma or cardiac conduction disorders.

Dorlol 5ml Eye Drops are prescription-required. Submit your valid prescription via email: sales@derma.pk or WhatsApp: +92-320-5999650. Nationwide delivery available across Pakistan.

Usage & Benefits
  • Dual-action IOP reduction via carbonic anhydrase inhibition and beta-blockade
  • Effective in open-angle glaucoma, pseudoexfoliative glaucoma, and ocular hypertension
  • Reduces risk of progressive optic nerve damage and vision loss
  • Topical administration delivers targeted effect with minimal systemic absorption
  • Superior to monotherapy in patients with inadequately controlled IOP
How To Use

Use only as directed by your healthcare provider.
1. Wash hands thoroughly before use.
2. Remove contact lenses before instillation and wait at least 15 minutes before reinserting.
3. Instil 1 drop in the affected eye(s) twice daily, or as prescribed by your ophthalmologist.
4. Avoid touching the dropper tip to the eye, eyelid, or any surface to prevent contamination.
5. If using other eye drops, wait at least 5 minutes between different medications.

FAQs

What is Dorlol 5ml Eye Drops used for?

Dorlol Eye Drops reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, combining Dorzolamide and Timolol for superior IOP control.

Can I wear contact lenses while using Dorlol?

Remove contact lenses before instilling Dorlol and wait at least 15 minutes before reinserting them, as the preservative benzalkonium chloride can be absorbed by soft lenses.

Is Dorlol safe in patients with asthma?

Caution is advised. Timolol in Dorlol is a beta-blocker and may cause bronchospasm in susceptible patients. Inform your ophthalmologist of any respiratory conditions before starting treatment.